[Why not always diuretics?].
New guidelines adopted in Norway for antihypertensive medication implies prescription of a thiazide diuretic as the drug of first choice. The background for the change in the rules for prescription drugs paid for by the National Insurance system with a capped co-payment is a resolution of the Norwegian parliament as part of a budget compromise for 2004. The resolution was supported by results from the ALLHAT study (antihypertensive and lipid-lowering treatment to prevent heart attack trial). ALLHAT was carried out in a group of elderly, high-risk patients with a large proportion of Afro-Americans. ALLHAT has important shortcomings with regard to design, results, analysis and interpretation. The trial is considered unfit as a basis for general guidelines on antihypertensive treatment in Norway.